| Company Name |
Cohance Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
543064 |
| Year End |
202603 |
| Full Year |
| Equity (Rs.Cr.) |
38.26 |
| B.V. Rs. |
117.10 |
| Sales Rs. Cr. |
2,030.50 |
| NP Rs. Cr. |
250.20 |
| NP Var% |
-8.00 |
| Div% |
0.00 |
| CPS Rs. |
10.00 |
| EPS Rs. |
6.50 |
| Traded Value(Rs.Lakhs) |
1,723.71 |
| 52 Week High |
1,180.00 |
| 52 Week Low |
268.00 |
| Price BSE |
419.00 |
| Price NSE |
419.00 |
| Market Capital(Rs. Cr.) |
16,010.43 |
| P/C Ratio |
41.80 |
| P/E Ratio |
64.10 |
| Price Vs.BV |
3.58 |
| Year End |
202603 |
| Sales Rs. Cr. |
567.55 |
| NP Rs. Cr. |
44.67 |
| NP Var % |
-67.00 |
| Year End |
202603 |
| Sales |
914.50 |
| OPM |
38.79 |
| NP |
247.20 |
| NP Var% |
-7.94 |
| EPS |
6.54 |
| PE |
63.99 |
|
|